Your browser is no longer supported. Please, upgrade your browser.
Settings
GLQ Clough Global Equity Fund daily Stock Chart
GLQ [NYSE]
Clough Global Equity Fund
Index- P/E- EPS (ttm)-1.07 Insider Own8.25% Shs Outstand17.65M Perf Week-0.74%
Market Cap214.13M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.08%
Income- PEG- EPS next Q- Inst Own26.50% Short Float- Perf Quarter12.26%
Sales5.94M P/S36.06 EPS this Y- Inst Trans-9.91% Short Ratio0.22 Perf Half Y12.34%
Book/sh12.70 P/B0.96 EPS next Y- ROA- Target Price- Perf Year26.43%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.26 - 12.28 Perf YTD11.75%
Dividend1.19 P/FCF- EPS past 5Y0.00% ROI- 52W High-1.22% Beta-
Dividend %9.81% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low30.94% ATR0.10
Employees- Current Ratio- Sales Q/Q16.60% Oper. Margin- RSI (14)62.41 Volatility0.96% 0.92%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.21 Prev Close12.09
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume85.75K Price12.13
Recom- SMA200.36% SMA503.01% SMA20012.63% Volume18,200 Change0.33%
Feb-28-17 10:00AM  Clough Global Equity Fund Business Wire
Feb-06-17 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Jan-31-17 10:00AM  Clough Global Equity Fund Business Wire
Jan-30-17 02:16PM  Saba Capital Management Invests in Clough Global Equity Fund
Jan-25-17 04:43PM  Clough Global Closed End Funds Portfolio Manager Departure Business Wire
Dec-30-16 10:00AM  Clough Global Equity Fund Business Wire
Dec-15-16 01:04PM  CLOUGH GLOBAL EQUITY FUND Financials
Dec-14-16 09:00AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Nov-30-16 10:00AM  Clough Global Equity Fund Business Wire
Nov-07-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Oct-31-16 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-31-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-08-16 09:30AM  Clough Global Equity Fund Announces Fund Distribution Rate Change and Declares Monthly Cash Distribution Business Wire
Jul-29-16 10:00AM  Clough Global Equity Fund Business Wire
Jun-30-16 10:00AM  Clough Global Equity Fund Business Wire
May-31-16 10:00AM  Clough Global Equity Fund Business Wire
May-06-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-29-16 09:30AM  Clough Global Equity Fund Business Wire
Mar-31-16 09:35AM  Clough Global Equity Fund Business Wire
Mar-09-16 09:30AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Feb-29-16 09:35AM  Clough Global Equity Fund Business Wire
Feb-08-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jan-29-16 09:30AM  Clough Global Equity Fund Business Wire
Dec-31-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-30-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Oct-30-15 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-15 09:35AM  Clough Global Equity Fund Business Wire
Aug-31-15 09:30AM  Clough Global Equity Fund Business Wire
Aug-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jul-31-15 09:35AM  Clough Global Equity Fund Business Wire
Jul-29-15 04:00PM  Clough Global Equity Fund Announces Voting Results from 2015 Annual Shareholder Meeting Business Wire
Jul-07-15 05:10PM  Clough Global Equity Fund Announces Annual Shareholder Meeting Business Wire
Jun-30-15 09:35AM  Clough Global Equity Fund Business Wire
May-29-15 09:30AM  Clough Global Equity Fund Business Wire
May-11-15 04:00PM  Clough Global Closed-End Funds Approve Participation Agreement Permitting Increased Share Purchases by RiverNorth Funds Business Wire
May-08-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-30-15 09:30AM  Clough Global Equity Fund Business Wire
Apr-20-15 04:00PM  Clough Global Closed-End Funds Adopt Share Repurchase Programs Business Wire
Mar-31-15 10:00AM  Clough Global Equity Fund Business Wire
Feb-27-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-30-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-05-15 09:30AM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Dec-31-14 09:30AM  Clough Global Equity Fund Business Wire
Dec-11-14 04:15PM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Nov-26-14 10:00AM  Clough Global Equity Fund Business Wire
Oct-31-14 09:30AM  Clough Global Equity Fund Business Wire
Oct-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Sep-30-14 09:30AM  Clough Global Equity Fund Business Wire
Sep-12-14 09:30AM  Clough Global Equity Fund Announces Change to Fiscal Year End Business Wire
Aug-29-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-31-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-15-14 10:05AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: GLQ, HIO, ISD at TheStreet
Jul-08-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Jun-30-14 09:30AM  Clough Global Equity Fund Business Wire
Jun-13-14 10:00AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GLQ, AIF, TCPC at TheStreet
Jun-01-14 05:49AM  How I Made 7% Retirement Income Investing In CEFs at Seeking Alpha
May-30-14 09:30AM  Clough Global Equity Fund Business Wire
May-13-14 10:05AM  3 Stocks With Upcoming Ex-Dividend Dates: GLQ, BGCP, CNW at TheStreet
Apr-30-14 09:30AM  Clough Global Equity Fund Business Wire
Apr-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Mar-31-14 10:00AM  Clough Global Equity Fund Business Wire
Mar-13-14 10:00AM  Dividend Watch: 3 Stocks Going Ex-Dividend Friday: GLQ, DHY, PHD at TheStreet
Feb-28-14 09:30AM  Clough Global Equity Fund Business Wire
Feb-11-14 10:03AM  Tomorrow's Ex-Dividends To Watch: GLQ, MEN, MYD, BKH, AMP at TheStreet
Jan-31-14 09:00AM  Clough Global Equity Fund Business Wire
Jan-15-14 09:30AM  Clough Global Equity Fund Business Wire
Jan-14-14 10:00AM  Tomorrow's Ex-Dividends To Watch: GLQ, GNT, LDP, PKI, GMCR at TheStreet
Jan-06-14 10:00AM  3 With Upcoming Ex-Dividend Dates: GLQ, BSBR, NTAP at TheStreet
Dec-19-13 02:16PM  Clough Global Equity Fund Declares Final Quarterly Cash Distribution of $0.29 Per Share before Moving to New Monthly Distributions Business Wire
Dec-12-13 06:30AM  Clough Global Equity Fund Announces an Annual Increase in Cash Distribution Per Common Share and Changes Distribution Payments to Monthly Business Wire
Nov-26-13 01:27PM  How I Made 7% Income While Lowering Risk at Seeking Alpha
Oct-31-13 09:45AM  Clough Global Equity Fund Business Wire
Oct-09-13 03:02PM  Clough Global Equity Fund Revises Quarterly Cash Distribution Ex-Date and Record Date Business Wire
Oct-08-13 06:30AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-31-13 09:00AM  Clough Global Equity Fund Business Wire
Jul-25-13 03:59AM  The CEF Firecracker at Seeking Alpha
Jul-24-13 09:28AM  A High Income, Lower Risk CEF Portfolio For Retirees at Seeking Alpha
Jul-09-13 06:01PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-30-13 07:00AM  Clough Global Equity Fund Business Wire
Apr-16-13 10:00AM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Appointment of Vincent W. Versaci to the Board of Trustees Business Wire
Apr-02-13 12:27PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-31-13 05:32PM  Clough Global Equity Fund Business Wire
Jan-08-13 11:47AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Oct-05-12 02:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Sep-28-12 01:32PM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Resignation of Andrew C. Boynton Business Wire
Jul-03-12 09:32AM  A Diversified Approach To International Dividends at Seeking Alpha
Apr-03-12 01:16PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-23-12 07:27AM  Dividend Champs With Yields As High As 11.2% at Seeking Alpha
Jan-10-12 12:41PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-09-12 10:44AM  CEF Weekly Review: Convertibles Shine at Seeking Alpha
Dec-14-11 01:41PM  Clough Capital: 3 Interesting Closed-End Funds Are Quasi Hedge Funds at Seeking Alpha
Oct-28-11 12:00AM  Portfolio Insights by Brett Arends: Turmoil leaves closed-end funds on sale at MarketWatch
Oct-05-11 01:06PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-07-11 03:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-06-11 12:03PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-24-11 03:32PM  Growth Story In China Shifts Focus To Internal Consumer Driven Demand: Exclusive Interview From Eric A. Brock Of Clough Capital Partners Wall Street Transcript
Jan-10-11 03:20PM  [video] Daily Dividend Report: GG, AYI, GLO, GLQ, MVO at Forbes.com
Jan-07-11 04:18PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Clough Global Equity Fund is a closed ended equity mutual fund launched and managed by Clough Capital Partners, L.P. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental and quantitative analysis with a bottom up stock picking approach to create its portfolio, with focus on factors such as a company's competitive position, quality of company management, quality and visibility of earnings and cash flow, balance sheet strength, and relative valuation. The fund follows a theme-based investment process which involves focusing on such events as industry consolidation, technological change, an emerging shortage of a product or raw material, and changes in government regulations. It benchmarks the performance of its portfolio against the S&P 500 Index. Clough Global Equity Fund was formed on January 25, 2005 and is domiciled in the United States.
SCMP Sucampo Pharmaceuticals, Inc. daily Stock Chart
SCMP [NASD]
Sucampo Pharmaceuticals, Inc.
Index- P/E26.28 EPS (ttm)0.41 Insider Own0.10% Shs Outstand47.11M Perf Week-0.92%
Market Cap508.79M Forward P/E7.36 EPS next Y1.47 Insider Trans-88.75% Shs Float29.77M Perf Month-8.09%
Income18.50M PEG1.88 EPS next Q0.30 Inst Own55.10% Short Float23.18% Perf Quarter-17.87%
Sales230.10M P/S2.21 EPS this Y-42.20% Inst Trans32.85% Short Ratio6.74 Perf Half Y-18.37%
Book/sh3.88 P/B2.78 EPS next Y4.11% ROA3.90% Target Price17.29 Perf Year7.57%
Cash/sh- P/C- EPS next 5Y14.00% ROE13.80% 52W Range9.62 - 17.55 Perf YTD-20.30%
Dividend- P/FCF71.66 EPS past 5Y24.80% ROI9.60% 52W High-38.46% Beta1.41
Dividend %- Quick Ratio8.80 Sales past 5Y33.30% Gross Margin67.00% 52W Low12.27% ATR0.53
Employees139 Current Ratio9.50 Sales Q/Q31.80% Oper. Margin17.30% RSI (14)46.84 Volatility4.06% 4.85%
OptionableYes Debt/Eq1.74 EPS Q/Q50.30% Profit Margin8.00% Rel Volume0.58 Prev Close10.60
ShortableYes LT Debt/Eq1.74 EarningsMar 08 BMO Payout0.00% Avg Volume1.02M Price10.80
Recom2.30 SMA20-3.10% SMA50-5.26% SMA200-12.63% Volume606,800 Change1.89%
Mar-10-17Reiterated WallachBeth Buy $20 → $15
Mar-09-17Reiterated Mizuho Buy $16 → $14
Mar-06-17Reiterated Mizuho Buy $16
Dec-22-16Upgrade Mizuho Neutral → Buy $16
Nov-15-16Reiterated Maxim Group Buy $17 → $19
Nov-14-16Reiterated Mizuho Neutral $13 → $16
Sep-07-16Initiated Northland Capital Outperform
Aug-04-16Downgrade Mizuho Buy → Neutral $13
Aug-01-16Reiterated Maxim Group Buy $26 → $17
May-05-16Upgrade WallachBeth Hold → Buy $16
Apr-20-16Upgrade Mizuho Neutral → Buy $14
Mar-10-16Reiterated WallachBeth Hold $27 → $16
Mar-09-16Reiterated Maxim Group Buy $25 → $26
Jan-15-16Reiterated Mizuho Neutral $19 → $14
Nov-20-15Initiated Jefferies Hold $19
Nov-13-15Reiterated Mizuho Neutral $22 → $19
Oct-29-15Resumed ROTH Capital Buy $29
Oct-09-15Initiated Mizuho Neutral
Sep-03-15Initiated Leerink Partners Mkt Perform
Aug-27-15Reiterated WallachBeth Hold $24 → $27
Mar-16-17 05:50PM  Local drug company stocks react to Trump's proposed cuts to NIH, FDA at bizjournals.com
Mar-15-17 05:01PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference GlobeNewswire
Mar-14-17 01:04PM  SUCAMPO PHARMACEUTICALS, INC. Financials
10:11AM  Sucampo Pharmaceuticals (SCMP): Moving Average Crossover Alert
Mar-13-17 08:54AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-09-17 10:54AM  Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 -6.64%
10:53AM  Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed
Mar-08-17 10:20PM  Edited Transcript of SCMP earnings conference call or presentation 8-Mar-17 1:30pm GMT +7.11%
01:21PM  Here's Why Sucampo Pharmaceuticals Rose as Much as 13.3% Today at Motley Fool
10:08AM  Nasdaq Leads On Chips; Dow Dips As Caterpillar Off, Banks Up
09:11AM  Biotech Premarket Movers: Sucampo, Intellia, Cytokinetics
08:30AM  Sucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open
06:48AM  Sucampo tops 4Q revenue forecasts
06:36AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors
06:30AM  Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Feb-23-17 04:02PM  Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call GlobeNewswire
Feb-17-17 05:41PM  Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire
02:04PM  Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb-16-17 04:25PM  Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb-09-17 10:36AM  Glaxo (GSK) Beats on Q4 Earnings, Posts Dismal '17 View
06:30AM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference GlobeNewswire
Feb-07-17 10:56AM  Mallinckrodt (MNK) Tops on Earnings in Transition Quarter
Feb-06-17 08:19AM  Portola, HealthCare Royalty Partners Ink $150 Million Deal
Feb-03-17 08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
Feb-02-17 09:49AM  Novartis (NVS) Votubia Gets EU Approval for Label Expansion
07:21AM  Catabasis Hits 52-Week Low on Poor DMD Drug Study Data
Jan-31-17 10:45AM  Mylan (MYL) Gets Favorable Verdict for Copaxone in the US
Jan-30-17 04:19PM  Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)
10:20AM  Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid
Jan-27-17 02:42PM  AbbVie (ABBV) Q4 Earnings Meet Estimates, Revenues Lag
09:05AM  Endo (ENDP) Restructures its Branded Pharmaceutical Unit
Jan-26-17 03:29PM  Celgene (CELG) Misses on Earnings & Revenues, Keeps View
Jan-23-17 05:26PM  Gilead (GILD) HCV Therapy Application Validated in Europe
05:22PM  Bristol-Myers Settles Litigation with Merck for Keytruda
08:28AM  Prima Biomed Initiates Randomized Study for Breast Cancer
Jan-19-17 09:04AM  Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan-18-17 08:29AM  Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo
08:26AM  Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan-17-17 09:30AM  Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo Pharmaceuticals -5.60%
08:28AM  Key FDA Events to Watch Out for in Q1
Jan-16-17 08:16AM  4 Profitable Stocks with Amazingly High Returns
08:09AM  5 Top Ranked Stocks with Upgraded Broker Ratings to Buy Now
Jan-13-17 09:55AM  Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan-12-17 04:19PM  TherapeuticsMD's Rejoice Study Data Published in Journal
08:43AM  Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
Jan-11-17 04:42PM  Valeant Streamlines Portfolio with Skincare Brands Sale
09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Insulet, Western Refining, PennyMac Mortgage Investment Trust and Extended Stay America
08:27AM  Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan-10-17 06:03PM  5 Underperformers of 2016: Turnaround Story in 2017?
09:30AM  Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE Financial
Jan-09-17 08:23AM  Go Driehaus Way: 5 Momentum Picks
07:32AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-06-17 10:18AM  Top Ranked Growth Stocks to Buy for January 6th
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
08:51AM  Why Sucampo Pharmaceuticals (SCMP)Could Be an Impressive Growth Stock
Jan-03-17 08:32AM  3 Overlooked Drug Stocks to Watch Out for in 2017
Dec-29-16 09:30AM  Zacks.com featured highlights: Calavo Growers, Cytokinetics, Sucampo Pharmaceuticals, State National and CryoLife
Dec-28-16 07:37AM  5 Profitable Stocks to Buy for Great Returns
Dec-27-16 04:17PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
09:07AM  Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up
07:11AM  4 Top Stocks with Earnings Acceleration to Buy in 2017
Dec-23-16 11:22AM  Trump, Interest Rates And Biotech Investing In 2017 at Forbes
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
Dec-22-16 01:19PM  Sucampo Pharmaceuticals, Inc. (SCMP) Announces Its New Debt Offering Of Convertible Notes at Insider Monkey
09:43AM  Sucampo Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCMP) : December 22, 2016
06:14AM  Sucampo Pharma upgraded by Mizuho
Dec-21-16 04:15PM  Stock Indexes Calm; Southwestern Energy Up 6%
07:32AM  Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : December 21, 2016
02:00AM  Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021 GlobeNewswire
Dec-20-16 05:40PM  Why NeoPhotonics, Sucampo Pharmaceuticals, and Worthington Industries Slumped Today at Motley Fool -20.48%
02:50PM  Here's Why Sucampo Pharmaceuticals Is Down Over 20% Today at Motley Fool
01:36PM  Dow Flirts With 20,000 As Caterpillar, Goldman Sachs, Nike Score Gains
Dec-19-16 04:06PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.03%
04:01PM  Sucampo Announces Proposed Convertible Senior Note Offering GlobeNewswire
01:47PM  Big-Cap Tech Names, Biotechs, Oils Lifting Market
08:47AM  Agios Stops Development of PKR Activator AG-519, Stock Falls
Dec-16-16 08:17AM  Roche (RHHBY) to Terminate Pacifica Bioscience Agreement
Dec-15-16 06:27AM  athenahealth (ATHN) Reaffirms 2016 View, Guides for 2017
Dec-14-16 09:17AM  Envision Healthcare Acquires Desert Mountain Consultants
08:09AM  Eli Lilly (LLY) to Offer Discount on Insulin from January
07:58AM  Kite Pharma Enters into Partnership with Vitruvian Networks
07:39AM  Proteon Slips to 52-Week Low on Kidney Disease Study Data
Dec-13-16 02:04PM  Top 10 Stocks Under $20
11:10AM  Stocks Stay Higher Ahead Of Fed; Dow Starts Eyeing 20,000
Dec-08-16 10:08AM  Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK
09:30AM  Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, Citrix Systems, VMware and Sanchez Energy
09:00AM  Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs
Dec-07-16 10:01AM  5 Stocks to Buy for Remarkable Earnings Growth in 2017 -5.51%
09:30AM  The Zacks Analyst Blog Highlights: Health Insurance Innovations, Aegean Marine Petroleum Network, KVH Industries, Sucampo Pharmaceuticals and Willdan Group
09:07AM  Sage Therapeutics Stock Up on SAGE-547 Regulatory Update
09:00AM  Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
08:55AM  Theravance Stock Up on Fast Track Status for Velusetrag
Dec-06-16 10:21AM  5 Best Small-Cap Stocks for 2017
08:24AM  GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
Dec-05-16 03:21PM  Is Sucampo Pharmaceuticals, Inc. (SCMP) A Good Stock To Buy? at Insider Monkey
Dec-01-16 10:23AM  Heat Biologics Stock Falls on Negative Bladder Cancer Data
08:25AM  Achaogen (AKAO) Catches Eye: Stock Adds 6.5% in Session
Nov-30-16 05:22PM  Cytori Scleroderma Study Two-Year Follow-Up Data Published -5.25%
09:53AM  PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The company's marketed product includes AMITIZA (lubiprostone), a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation in adult women (IBS-C), opioid-induced constipation (OIC)in patients with chronic non-cancer pain, and chronic constipation; and RESCULA (unoprostone isopropyl), a big potassium channel activator for the treatment of glaucoma and ocular hypertension. Its product candidates in clinical development stage comprise Lubiprostone that is in Phase IV clinical trials for the treatment of irritable bowel syndrome with constipation in adult women; Phase III clinical trials for the treatment of pediatric functional constipation and (IBS-C); and completed Phase III clinical trials for the treatment of (CIC) in adults, IBS-C in adult women, and OIC in patients with chronic non-cancer pain, as well as CPP-1X/sulindac combination product, which has completed Phase III clinical trials for the treatment of familial adenomatous polyposis. Sucampo Pharmaceuticals, Inc. was founded in 1996 is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Getman Daniel PDirectorNov 29Option Exercise6.803,79925,8333,799Nov 30 04:01 PM
Greenleaf PeterCEONov 29Option Exercise6.7582,459556,59884,972Nov 30 04:01 PM
Greenleaf PeterCEONov 29Sale16.7582,4591,381,1882,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 29Sale16.753,79963,6330Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Option Exercise6.8016,201110,16716,201Nov 30 04:01 PM
Greenleaf PeterCEONov 28Option Exercise6.75117,541793,402120,054Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Option Exercise8.3324,975208,04228,424Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Sale16.7324,975417,8323,449Nov 28 09:30 PM
Greenleaf PeterCEONov 28Sale16.91117,5411,987,6182,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Sale16.8916,201273,6350Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Option Exercise8.3399,025824,878102,474Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Sale15.8899,0251,572,5173,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Option Exercise8.3326,000216,58029,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Sale15.7726,000410,0203,449Nov 28 09:30 PM
Smith Andrew PChief Financial OfficerNov 15Sale15.581,76627,514348Nov 16 04:01 PM
CS Credit Suisse Group AG daily Stock Chart
CS [NYSE]
Credit Suisse Group AG
Index- P/E- EPS (ttm)-1.18 Insider Own3.10% Shs Outstand2.09B Perf Week-1.90%
Market Cap31.27B Forward P/E9.52 EPS next Y1.57 Insider Trans0.00% Shs Float1.93B Perf Month0.34%
Income-2458.00M PEG- EPS next Q- Inst Own3.40% Short Float0.25% Perf Quarter0.07%
Sales17.49B P/S1.79 EPS this Y23.60% Inst Trans38.68% Short Ratio0.98 Perf Half Y11.33%
Book/sh20.07 P/B0.74 EPS next Y44.43% ROA-0.30% Target Price17.85 Perf Year9.38%
Cash/sh206.26 P/C0.07 EPS next 5Y0.30% ROE-6.20% 52W Range10.01 - 16.17 Perf YTD4.40%
Dividend0.72 P/FCF1.21 EPS past 5Y-24.80% ROI2.90% 52W High-7.61% Beta1.54
Dividend %4.82% Quick Ratio- Sales past 5Y-5.50% Gross Margin- 52W Low49.25% ATR0.34
Employees47690 Current Ratio- Sales Q/Q-15.80% Oper. Margin42.10% RSI (14)44.55 Volatility2.82% 1.73%
OptionableYes Debt/Eq4.61 EPS Q/Q58.60% Profit Margin-15.60% Rel Volume1.34 Prev Close14.67
ShortableYes LT Debt/Eq4.61 EarningsFeb 14 BMO Payout- Avg Volume4.88M Price14.94
Recom2.00 SMA20-1.88% SMA50-1.95% SMA2009.80% Volume6,434,000 Change1.84%
Feb-17-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-13-17Downgrade Macquarie Neutral → Underperform
Nov-14-16Upgrade BofA/Merrill Neutral → Buy
Nov-10-16Upgrade Keefe Bruyette Mkt Perform → Outperform
Nov-04-16Downgrade Macquarie Outperform → Neutral
Jun-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform
Jun-27-16Downgrade JP Morgan Neutral → Underweight
Jun-13-16Downgrade Keefe Bruyette Outperform → Mkt Perform
May-20-16Upgrade BofA/Merrill Underperform → Neutral
Apr-05-16Downgrade Exane BNP Paribas Neutral → Underperform
Feb-23-16Upgrade Macquarie Underperform → Outperform
Feb-16-16Downgrade JP Morgan Overweight → Neutral
Feb-05-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-01-15Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-06-15Downgrade RBC Capital Mkts Outperform → Sector Perform $26
Feb-08-13Reiterated RBC Capital Mkts Outperform $27 → $30
Jan-05-10Initiated Barclays Capital Equal Weight
Nov-02-09Upgrade Citigroup Hold → Buy
Aug-20-09Upgrade FBR Capital Underperform → Mkt Perform
Jul-28-09Downgrade FBR Capital Mkt Perform → Underperform
Mar-27-17 11:54PM  Credit Suisse's Garthwaite Sees Equities Creeping Upwards
09:32PM  Credit Suisse Progress Buys Thiam Breathing Room on Capital
09:32PM  Credit Suisse CEO Says Considering Options to Plug Capital Hole
09:14PM  Credit Suisse CEO Sees Brexit and Capital Options
08:41PM  Credit Suisse CEO Thiam Sees Options for Bank on Brexit
10:30AM  Credit Suisse Mulls Share Sale Instead of Swiss Unit IPO
09:24AM  Credit Suisse (CS) Increases Bonus to Retain Employees
Mar-26-17 08:29AM  [$$] Credit Suisse pays out SFr250m to retain top bankers and traders at Financial Times
Mar-24-17 01:14PM  [$$] Curious Quirks in How Credit Suisse Makes Money at The Wall Street Journal
12:54PM  Credit Suisse Boosts Bonus Pool by $3.1 Billion
12:25PM  [$$] Credit Suisse boosts bonuses despite large annual loss at Financial Times
07:26AM  Credit Suisse's Dilution a Capital Boost Concern
06:18AM  Credit Suisse CEO pockets $12 million despite back-to-back losses Reuters
02:26AM  Credit Suisse Increases Bonus Pool 6%, CEO Thiam Gets $12 Million
01:00AM  Keeping the Deutsche Wolf from Credit Suisse's Door
Mar-23-17 03:22PM  Credit Suisse Said to Weigh Stock Sale
01:11PM  European stocks break 3-day losing streak as investors eye U.S. health care vote at MarketWatch
12:46PM  Credit Suisse shares drop 2% on reports of $3 billion share sale at MarketWatch
11:28AM  Credit Suisse considers stock sale over Swiss IPO: sources Reuters
10:44AM  Credit Suisse Said Weighing Share Sale Over Swiss IPO
09:48AM  Credit Suisse Said to Weigh Stock Sale Instead of Swiss IPO
07:03AM  Swiss Fraud Probe May Expand to Include Credit Suisse Employees
Mar-22-17 10:53AM  Credit Suisse Is Stuck in Neutral
09:06AM  Factors that Led to a Slew of Upgrades for Vale SA
06:37AM  European Banks Hit Hard As Bonds Rally, ECB Cautions on Early Stimulus Exit
Mar-21-17 10:24AM  UBS Group AG (UBS) to Stand Trial for Tax Evasion in France
05:00AM  Deutsche Bank Said to Face Regulatory Fines Over Currency Trades
05:00AM  Deutsche Bank Said to Face Fines Over Currency Trades
Mar-20-17 11:26AM  Credit Suisse (CS) Cuts Equities Business Jobs in Asia
Mar-17-17 02:14AM  Credit Suisse Said to Cut About Half a Dozen Asia Equities Jobs
Mar-16-17 10:11AM  Deutsche Bank (DB) Likely to Vend Indian Retail Business
08:18AM  Canada Goose Prices IPO at C$17
Mar-14-17 04:41PM  Valuations, Panic Hit Record Levels: 5 Safe Bets
09:34AM  Commodities Slightly Increased Amid Uncertainty PR Newswire
Mar-10-17 07:57AM  What Feb. Jobs Report Means to the Federal Reserve
Mar-09-17 04:05PM  Credit Suisse AG Announces the Reverse Splits of its DGAZ, VIIX, TVIX and TVIZ ETNs PR Newswire
06:44AM  Market Recon: Watch the Euro and Big Banks Like Deutsche and Credit Suisse
Mar-08-17 01:34PM  HSBC Sells Mortgage Business to Cerdit Suisse (HSBC, CS) at Investopedia
Mar-07-17 05:27AM  NLMK CEO Says More Russian Steel Consolidation Not Needed
Mar-06-17 06:34PM  Deutsche Bank (DB) to Raise $8.5B Capital, Sets New Targets
12:00PM  [video]Deutsche Bank May Open the Way for Cash Raising by European Banks
Mar-03-17 08:32AM  Credit Suisse Preps for Possible Swiss Unit IPO
Mar-02-17 08:30AM  Credit Suisse Announces Coupon Payments and Expected Coupon Payments on Credit Suisse X-Links Exchange Traded Notes (the "ETNs") PR Newswire
08:21AM  Osmar Abib Sees 'Substantial' Oil Deals, Equity Issuance
07:36AM  Why Are Vale Analysts Are Feeling Upbeat?
Mar-01-17 02:20PM  Credit Suisse Predicts Paltry 3.5% Growth for Hedge Funds in 2017 at Investopedia
11:20AM  Credit Suisse CFO Sees Bank's Growth Slowing Capital Build
04:57AM  European Stocks Gain as Banks Surge on Fed Rate Hike Speculation
Feb-28-17 12:26PM  Why Hedge Fund Investors Are Aiming Higher This Year
11:00AM  Credit Suisse Releases 9th Annual Hedge Fund Investor Survey PR Newswire
Feb-27-17 09:46AM  David Herro on Trump's Message, Banks, and Glencore
07:37AM  What Analysts Recommend for DuPont
Feb-24-17 01:18PM  Will Bond Market Rally Take a Break amid Interest Rate Hikes?
07:13AM  MOVES-Credit Suisse makes two senior India appointments
Feb-23-17 09:12AM  [$$] Credit Suisse Probe Opens Old Wounds at The Wall Street Journal
05:04AM  Credit Suisse to Commit $600 Million for Saudi Expansion
12:19AM  [$$] Credit Suisse Probe Opens Old Wounds at The Wall Street Journal
Feb-21-17 04:11PM  Credit Suisse Offers Brighter Outlook on Europe at Investopedia
12:36AM  [$$] Whats Lurking in Credit Suisses Fat Margins at The Wall Street Journal
Feb-20-17 06:01PM  Credit Suisse Returns to Its Roots in Europe
05:52AM  [$$] What's Lurking in Credit Suisse's Fat Margins at The Wall Street Journal
Feb-17-17 05:32PM  Moody's assigns rating to a new structured note issued by Mortgage Repurchase Agreement Financing Trust, Series 2016-1 at Moody's
11:17AM  Credit Suisse Group AG :CS-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017
07:22AM  Credit Suisse upgraded by Morgan Stanley
Feb-16-17 09:37AM  Credit Suisse Group AG :CS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 16, 2017
Feb-15-17 02:49PM  5 China Stocks to Buy as Red Dragon Outshines Asia
09:16AM  Credit Suisse (CS) Reports Loss in Q4 on DOJ Settlement
06:00AM  Why For-Profit Colleges Could Thrive Under Trump at Investopedia
04:29AM  Credit Suisse Boosts Senior Asia Banker Pay by Up to 15% at Bloomberg
Feb-14-17 09:42PM  Credit Suisse Keeps Losing Money, Plans More Layoffs at Investopedia
05:12PM  Credit Suisse announces more layoffs; RTP impact unclear at bizjournals.com
12:23PM  Credit Suisse CEO Thiam on Cost Cuts, Volatility, Brexit
12:23PM  European stocks eke out a gain after GDP miss, keep win streak intact at MarketWatch
11:39AM  Credit Suisse Posts Loss, but Investors Eye Its 2017 Start at The Wall Street Journal
10:51AM  Credit Suisse Posts Loss Amid Justice Department Settlement at TheStreet
10:26AM  Finding Positives in Credit Suisse's 4Q Results
09:38AM  Stocks Move Lower Ahead of Yellen Testimony
09:32AM  Credit Suisse reports 4Q loss
09:28AM  [$$] Credit Suisse's Universally Bad Idea at The Wall Street Journal
09:15AM  Credit Suisse's Vexing Earnings Changes at The Wall Street Journal
08:57AM  Credit Suisse flags 6,500 job cuts in 2017 after $2.4 billion loss Reuters
08:23AM  Credit Suisse FX Strategist Watches for Disruptive Brexit
07:34AM  This Is What Caused Credit Suisse Shares to Open With a Bang on Tuesday
07:10AM  Credit Suisse Stock Rises on Revenue Growth at TheStreet
05:59AM  Credit Suisse Needs More Trump Bumps at Bloomberg
05:55AM  Is Credit Suisse on the Path to Recovery?
03:50AM  [$$] Credit Suisse changes tack on Swiss IPO amid stronger capital at Financial Times
03:03AM  Credit Suisse Posts Loss on DoJ Fine
02:14AM  Credit Suisse CEO Thiam Says Climate Is Better for Banks
01:15AM  Credit Suisse Plans to Cut Up to 6,500 Jobs This Year After Loss at Bloomberg
Feb-13-17 05:10PM  Credit Suisse 2016 net loss of 2.4 bn Swiss francs AFP
11:32AM  [$$] Listing of Credit Suisse's domestic operations facing opposition at Financial Times
Feb-09-17 10:01AM  Moody's ABCP rating activity ending February 3, 2017 at Moody's
09:20AM  Commodities Slightly Increased Amid Uncertainty PR Newswire
Feb-08-17 09:06AM  Do Distressed Valuations Mean Its a Good Time to Buy Deutsche Bank?
Feb-06-17 04:30PM  Credit Suisse Group AG -- Moody's assigns Ba2(hyb) rating to Credit Suisse Group AG's high-trigger AT1 capital securities at Moody's
03:42PM  Here's Your Sell-Side Conference Preview
08:30AM  Credit Suisse Announces Coupon Payments and Expected Coupon Payments on Credit Suisse X-Links Exchange Traded Notes (the "ETNs") PR Newswire
07:41AM  Credit Suisse Could Forgo Swiss IPO to Sell Own Stock: UBS at Bloomberg
Feb-03-17 09:07AM  What to Expect from Danahers Future Earnings
Credit Suisse Group AG, together with its subsidiaries, provides various financial services worldwide. It operates through Swiss Universal Bank, International Wealth Management, Asia Pacific, Global Markets, and Investment Banking & Capital Markets segments. The company offers a range of advice and financial solutions, including structured advisory; investment advice; wealth and asset management; fixed income products and instruments; securitized products; M&A transactions; corporate sales and restructurings; divestitures; takeover defense strategies; equity and debt underwritings; equity and fixed income sales; debt and equity securities; private placements; and trading services, as well as derivative products. It also offers various banking services, such as lending, payment, capital goods leasing, syndications and structured finance, trade finance, ship and aviation finance, export finance and factoring, treasury, and foreign exchange services, as well as fund solutions and fund-linked services. In addition, the company provides global securities sales, trading and execution, prime brokerage, and investment research services; and investment solutions and services to pension funds, foundations and endowments, and individuals. It operates 447 offices and branches. The company offers its products and services to private, corporate, institutional, high-net-worth and ultra-high-net-worth individuals, small and medium-sized enterprises, governments, and institutional investors, as well as affluent and retail clients. Credit Suisse Group AG was founded in 1856 and is based in Zurich, Switzerland.